CareLit · DOI-Nachweis · Aktuelle Neurologie
Bevacizumab induces regression of vestibular schwannomas leading to improved hearing in neurofibromatosis type 2 patients
DOI 10.1055/s-0029-1238749
Bibliografische Angaben
Nachweis in CareLit
Autor:innenVF Mautner, R Nguyen, H Kutta, C Fuensterer, C Bokemeyer, C Hagel, RE Friedrich, SR Scott, J Panse
ZeitschriftAktuelle Neurologie
Ausgabe10/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Bilateral vestibular schwannomas are the hallmark of neurofibromatosis type 2 which impair hearing and lead frequently to deafness. Neurosurgical intervention, the only established treatment, often damages the vestibular nerve. We report two cases in which 3- and 6-month treatment of bevacizumab induced significant regression of progressive vestibular schwannomas by over 40% and improved hearing significantly in the…
Zitieren
Zitierempfehlung
VF Mautner, R Nguyen, H Kutta, C Fuensterer, C Bokemeyer, C Hagel, RE Friedrich, SR Scott, J Panse (2009) Bevacizumab induces regression of vestibular schwannomas leading to improved hearing in neurofibromatosis type 2 patients. Aktuelle Neurologie (10). https://doi.org/10.1055/s-0029-1238749
Mit CareLit weiterarbeiten